Graphene Services Pte Ltd

Graphene Services Pte Ltd Graphene with a simple vision to build decision platforms which transform the way senior leaders make easy and robust data based decisions.

Our AI based Market research for insulin in the US market revealed some interesting insights. Here’s a sneak-peak on wha...
15/06/2022

Our AI based Market research for insulin in the US market revealed some interesting insights. Here’s a sneak-peak on what is driving HCPs in prescribing insulin drugs.

60% HCPs - Consider Early onset of Microvascular complications
56% HCPs – Consider weight fluctuation of more than 11 pounds
46% HCPs – Consider insurance and patient's ability to bear the treatment cost

These insights are just the tip of an iceberg, would you like to know more?

Watch a quick video - https://bit.ly/39qqokl

24/05/2022

Delivering value to Pharma clients across the world has been very exciting!!

Every day we address real-world pharma industry challenges with the help of AI Driven Insights.

If you are working in the Rare Disease area and want help finding actionable insights, we can help!!

What makes us different - a large audience sample, unbiased methodology and fast and cost-effective ex*****on and most importantly, little effort from your side.

See how we delivered ‘Patient Insights’ in .

Link - https://lnkd.in/d_YXsPSs
Let's Talk - https://bit.ly/GrapheneAI

It is proving challenging to get actionable insights about Rare Diseases, especially with a traditional approach. Gettin...
02/05/2022

It is proving challenging to get actionable insights about Rare Diseases, especially with a traditional approach. Getting data and analyzing it from such a small community of people sounds difficult, isn’t it?

Not anymore!

GrapheneAI can augment your existing insights with a large sample, unbiased methodology and fast and cost-effective ex*****on. Most importantly, with little effort from your side.

Want to know how we deliver these Top 5 Insights for global pharma in Hemophilia, Spinal Muscular Atrophy, Huntington’s Disease, Fabry Disease, Gaucher’s Disease and Other Rare Diseases?

Book a Free Demo: https://app.bitly.com/Bm3a6H4wYAf/bitlinks/3s0iOmP

Do you know how top pharma companies keep up to date with the ever-emerging trends in rare diseases? A small community o...
27/04/2022

Do you know how top pharma companies keep up to date with the ever-emerging trends in rare diseases?

A small community of HCPs and patients, constant advancements in tech, and continuous changes in treatment options are some of the challenges Pharma companies face in Rare Diseases. Here’s how GrapheneAI finds and delivers insights:

AI Driven Solution

- Identify HCP & Patient Perception and behavior
- Track emerging trends in testing, diagnosis, and treatment
- Uncover drivers of prescription & patient archetypes
- And a lot more!

GrapheneAI finds insights with high accuracy and precision. Actionable insights derived from spontaneous online opinions! Augment your understanding of HCPs, Patients, and Caregivers. Want to see how we do it?

Book a Free Demo: https://bit.ly/GrapheneAI

20/04/2022

Congratulations Team Graphene!

We are proud to announce that now GrapheneAI is Triple Microsoft Gold Partner Certified.

Gold Data Analytics | Gold Data Platform | Gold Cloud Platform.

We take this special moment to thank each and everyone involved in the process – Technology Savvy colleagues and visionary leaders.

This is yet another milestone in our consistent journey towards empowering business decisions with the power of Technology.

Would you like to talk to us about it?

We’re all ears – Book a Meeting with one of our AI-Market Research Expert.

Link: https://bit.ly/GrapheneAI

From traditional chemotherapy to Targeted Therapy, Oncology market landscape is experiencing a rapid shift. Did you know...
05/04/2022

From traditional chemotherapy to Targeted Therapy, Oncology market landscape is experiencing a rapid shift. Did you know that 70% of the potential oncology patients don’t even go for the mutational analysis test recommended by the HCPs?

Here’s what we found: While cost is a factor, lack of clarity in HCP communication and conflicting second opinions are reasons why only 30% of oncology patients get tested.

At Graphene, we are working with top 7 of the 12 Pharma companies across 35 countries to empower them with actionable insights. Click here to Schedule a Free Demo: https://bit.ly/AI_DemoRequest

In a recent analysis by Graphene AI, 44% of HCPs have mentioned peer group influence as one of the top reasons to prescr...
23/03/2022

In a recent analysis by Graphene AI, 44% of HCPs have mentioned peer group influence as one of the top reasons to prescribe a drug!! A great opportunity for pharma companies.

Are you developing brand ambassadors among prescribing HCPs for your drugs? Graphene can help you discover unbiased and actionable insights like these in 6 to 8 weeks to help you in your strategic planning and ex*****on.

Top global pharma companies are moving towards AI-based market research, and we are excited to help partner with them to deliver ‘faster, economical, and smarter’ insights. Discover why 7 of the top 12 Pharma Companies work with us across 35 countries.

Click here to Request a Free Demo: https://bit.ly/AI_DemoRequest

Engaging with oncology HCPs is crucial but challenging for Pharma Industry. Did you know that the medical rep ranks 2nd ...
15/03/2022

Engaging with oncology HCPs is crucial but challenging for Pharma Industry. Did you know that the medical rep ranks 2nd in Reach, but 5th in Impact? Graphene can help you discover unbiased insights like these in 6 to 8 weeks.

Top global pharma companies are moving towards AI-based market research, and we are excited to help partner with them to deliver ‘faster, economical, and smarter’ insights. Discover why 7 of the top 12 Pharma Companies work with us across 35 countries.

Click here to Request a Free Demo: https://lnkd.in/eXF2pN-g

We are proud to announce that Graphene is a winner of Emerge 50 2020! This award recognizes the disruption that Graphene...
26/11/2020

We are proud to announce that Graphene is a winner of Emerge 50 2020!

This award recognizes the disruption that Graphene has engineered through AI-based market research in the domains of Pharma, FMCG and FSI. This recognition is also a testament to the deep-tech capability, domain expertise and business understanding that has helped differentiate Graphene across the world.

Graphene AI’s proprietary algorithm can distinguish between bot, doctor and patient conversations. Find out more here: h...
01/09/2020

Graphene AI’s proprietary algorithm can distinguish between bot, doctor and patient conversations.

Find out more here: https://www.graphenesvc.com/.

We are proud to announce that Graphene Services is part of the NASSCOM DeepTech Club. This prestigious membership recogn...
26/07/2020

We are proud to announce that Graphene Services is part of the NASSCOM DeepTech Club. This prestigious membership recognizes our cutting-edge AI solutions for the pharmaceutical, consumer and financial industries.

Address

28 Genting Lane #08-08 Platinum 28
Singapore
349585

Alerts

Be the first to know and let us send you an email when Graphene Services Pte Ltd posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to Graphene Services Pte Ltd:

Share